582 related articles for article (PubMed ID: 24802511)
1. Use of pressurized metered dose inhalers in patients with chronic obstructive pulmonary disease: review of evidence.
Aggarwal B; Gogtay J
Expert Rev Respir Med; 2014 Jun; 8(3):349-56. PubMed ID: 24802511
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
[TBL] [Abstract][Full Text] [Related]
3. Factors guiding the choice of delivery device for inhaled corticosteroids in the long-term management of stable asthma and COPD: focus on budesonide.
Thorsson L; Geller D
Respir Med; 2005 Jul; 99(7):836-49. PubMed ID: 15939245
[TBL] [Abstract][Full Text] [Related]
4. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
[TBL] [Abstract][Full Text] [Related]
5. Inhalatory therapy training: a priority challenge for the physician.
Melani AS
Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
[TBL] [Abstract][Full Text] [Related]
6. The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients.
Darbà J; Ramírez G; Sicras A; Francoli P; Torvinen S; Sánchez-de la Rosa R
Int J Chron Obstruct Pulmon Dis; 2015; 10():2335-45. PubMed ID: 26604733
[TBL] [Abstract][Full Text] [Related]
7. A narrative review on the Synchrobreathe™: A novel breath-actuated pressurised metered-dose inhaler for the treatment of obstructive airway diseases.
Lavorini F; Usmani OS; Salvi S; Rote K; Gaur V; Gogtay J
Respir Med; 2023; 219():107435. PubMed ID: 38652077
[TBL] [Abstract][Full Text] [Related]
8. Inhaler devices for patients with COPD.
Fink JB; Colice GL; Hodder R
COPD; 2013 Aug; 10(4):523-35. PubMed ID: 23537191
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of budesonide and formoterol administered via 1 pressurized metered-dose inhaler in patients with asthma and COPD.
Tronde A; Gillen M; Borgström L; Lötvall J; Ankerst J
J Clin Pharmacol; 2008 Nov; 48(11):1300-8. PubMed ID: 18974284
[TBL] [Abstract][Full Text] [Related]
10. Clinical equivalence of budesonide dry powder inhaler and pressurized metered dose inhaler.
Srichana T; Juthong S; Thawithong E; Supaiboonpipat S; Soorapan S
Clin Respir J; 2016 Jan; 10(1):74-82. PubMed ID: 25043636
[TBL] [Abstract][Full Text] [Related]
11. Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study.
Sharafkhaneh A; Southard JG; Goldman M; Uryniak T; Martin UJ
Respir Med; 2012 Feb; 106(2):257-68. PubMed ID: 22033040
[TBL] [Abstract][Full Text] [Related]
12. Co-deposition of a triple therapy drug formulation for the treatment of chronic obstructive pulmonary disease using solution-based pressurised metered dose inhalers.
Adi H; Young PM; Traini D
J Pharm Pharmacol; 2012 Sep; 64(9):1245-53. PubMed ID: 22881437
[TBL] [Abstract][Full Text] [Related]
13. Budesonide and formoterol in a single pressurized metered-dose inhaler for treatment of COPD.
Tashkin DP
Expert Rev Respir Med; 2010 Dec; 4(6):703-14. PubMed ID: 21128746
[TBL] [Abstract][Full Text] [Related]
14. The Evolution of Pressurized Metered-Dose Inhalers from Early to Modern Devices.
Roche N; Dekhuijzen PN
J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):311-27. PubMed ID: 26824873
[TBL] [Abstract][Full Text] [Related]
15. Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients.
Dhand R
Respir Care; 2005 Oct; 50(10):1331-4; discussion 1344-5. PubMed ID: 16185369
[TBL] [Abstract][Full Text] [Related]
16. Inhalation devices for long-acting beta2-agonists: efficiency and ease of use of dry powder formoterol inhalers for use by patients with asthma and COPD.
Molimard M; Till D; Stenglein S; Singh D; Krummen M
Curr Med Res Opin; 2007 Oct; 23(10):2405-13. PubMed ID: 20350055
[TBL] [Abstract][Full Text] [Related]
17. Use of breath-actuated inhalers in patients with asthma and COPD - an advance in inhalational therapy: a systematic review.
Salvi S; Gogtay J; Aggarwal B
Expert Rev Respir Med; 2014 Feb; 8(1):89-99. PubMed ID: 24325614
[TBL] [Abstract][Full Text] [Related]
18. Co-suspension delivery technology in pressurized metered-dose inhalers for multi-drug dosing in the treatment of respiratory diseases.
Ferguson GT; Hickey AJ; Dwivedi S
Respir Med; 2018 Jan; 134():16-23. PubMed ID: 29413503
[TBL] [Abstract][Full Text] [Related]
19. The role of nebulized therapy in the management of COPD: evidence and recommendations.
Dhand R; Dolovich M; Chipps B; Myers TR; Restrepo R; Farrar JR
COPD; 2012 Feb; 9(1):58-72. PubMed ID: 22292598
[TBL] [Abstract][Full Text] [Related]
20. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.
Geller DE
Respir Care; 2005 Oct; 50(10):1313-21; discussion 1321-2. PubMed ID: 16185367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
